Bank Bonuses Exceed Profits, Thimerosal in Swine Flu Vaccines, Legal Immunity for Pharma
Revealing News Articles
August 10, 2009
Below are key excerpts of important news articles you may have missed. These articles include revealing information on a report that bonuses paid by the biggest Wall Street banks far exceed profits, plans to include mercury-laden thimerosal in swine flu vaccines, legal immunity for Big Pharma makers of the vaccines, and more. Each excerpt is taken verbatim from the major media website listed at the link provided. If any link fails to function, click here. The most important sentences are highlighted for those with limited time. By choosing to educate ourselves and to spread the word, we can and will build a brighter future.
Special note: For those who want to know how the Fed is likely manipulting a rise in stock prices which could set the stage for even worse economic depression, read the highly informative article available here.
Bank Bonuses Far Exceeded Profits
July 30, 2009, CBS News
Several financial giants that received federal bailout money in the last year paid out bonuses to employees in 2008 that greatly exceeded the amount of profit generated by the banks, according to a study on executive compensation released by New York State Attorney General Andrew Cuomo Thursday. Despite claims by bank executives that bonuses are tied to the company's performance, the report states that "there is no clear rhyme or reason to how the banks compensate or reward their employees." Cuomo's investigation "suggests a disconnect between compensation and bank performance that resulted in a 'heads I win, tails you lose' bonus system." According to the report: � Goldman Sachs, which earned $2.3 billion last year and received $10 billion in TARP funding, paid out $4.8 billion in bonuses in 2008 - more than double their net income. � Morgan Stanley, which earned $1.7 billion last year and received $10 billion in bailout funds, handed out $4.475 billion in bonuses, nearly three times their net income. � JPMorgan Chase, which earned $5.6 billion in 2008 and received $25 billion from the government, paid out $8.69 billion in bonus money. � Citigroup and Merrill Lynch lost a combined $54 billion last year. They received a total of $55 billion in bailouts and paid out $9 billion in combined bonuses. ($5.33 billion for Citigroup; $3.6 billion for Merrill Lynch, which was subsequently acquired by Bank of America.) Bonuses have been a hot-button issue surrounding these federally bailed out banks for months, with company executives facing heat from ... local officials like Cuomo angered by the exorbitant compensation plans for the same people widely seen as responsible for the country's financial crisis.
Legal immunity set for swine flu vaccine makers
July 20, 2009, MSNBC/Associated Press
The last time the government embarked on a major vaccine campaign against a new swine flu, thousands filed claims contending they suffered side effects from the shots. This time, the government has already taken steps to head that off. Vaccine makers and federal officials will be immune from lawsuits that result from any new swine flu vaccine, under a document signed by Secretary of Health and Human Services Kathleen Sebelius, government health officials said Friday. Since the 1980s, the government has protected vaccine makers against lawsuits over the use of childhood vaccines. The document signed by Sebelius last month grants immunity to those making a swine flu vaccine, under the provisions of a 2006 law for public health emergencies. It allows for a compensation fund, if needed. The government takes such steps to encourage drug companies to make vaccines, and it's worked. Federal officials have contracted with five manufacturers to make a swine flu vaccine. The last time the government faced a new swine flu virus was in 1976. Federal officials vaccinated 40 million Americans during a national campaign. A pandemic never materialized, but thousands who got the shots filed injury claims, saying they suffered a paralyzing condition called Guillain-Barre Syndrome or other side effects.
Note: Note for a powerfully revealing CBS report on blatant fear mongering and profiteering from the 1976 swine flue scare, click here. For many revealing reports on corruption in the medical/governmental complex, click here.
Flu Vaccine Panel Creates Priority List
July 30, 2009, Washington Post
A complicated list of who should get [swine] flu vaccine in the fall is now set. When the vaccine starts arriving in September, first in line will be pregnant women; the caretakers of infants; children and young adults; older people with chronic illness; and health-care workers. That's the advice of a 15-member committee of experts, which met all day Wednesday at the Centers for Disease Control and Prevention in Atlanta to advise the federal government on vaccine policy. The priority list names targeted groups and suggests the order in which they should be vaccinated. "The results of this meeting will kick planning into high gear," said Pascale Wortley of the CDC's Immunization Services Division. "This is a watershed moment." All that's missing is the vaccine, knowledge of how well it works and the nitty-gritty details of how to deliver it to people's arms and noses. The vaccine will come in two forms: the traditional flu shot and a "live" vaccine squirted into the nose that contains a weakened version of the new virus. Some of the vaccine will be stored in multi-dose vials containing thimerosal, an antibacterial additive that contains mercury. But there will also be single-dose syringes without thimerosal, a substance that some assert is harmful to children. Among the many unanswered questions is whether two doses will be necessary to provide full protection, how close in time two shots can be given and how big the dose will be. Vaccination programs may start before the answers are known.
Note: Why is thimerosal being used? It is a mercury additive around which there appears to be a major cover-up. For several other revealing articles which suggest an dangerous agenda with the swine flu vaccine, click here.
Will Safety Fears Hurt Swine Flu Vaccinations?
July 30, 2009, ABC News
With the U.S. Centers for Disease Control and Prevention hoping to have 120 million doses of H1N1 swine flu virus vaccine ready before flu season this fall, some are raising concerns over what they see as an effort to rush the drug through safety trials. The source of many of these concerns is the probability that the mercury-containing preservative thimerosal will be an ingredient in some of the doses of the new vaccine. Concern over thimerosal has lingered for years. Groups opposed to current vaccination practices continue to condemn thimerosal as a toxin responsible for the development of autism and related ailments in children. Additionally, the possibility that the swine flu vaccine could also contain an adjuvant, an ingredient that would allow more doses to be created from existing supplies of the vaccine, has also worried these groups. "We don't have adequate safety studies on this vaccine before we are moving forward to market," said Lyn Redwood, president and co-founder of the group SafeMinds. "I'm really not convinced that we know for sure that the risk of the disease outweighs the risk of the vaccine, especially since this is a brand new additive that we have never used before in combination with thimerosal." During the 1976-77 flu season, a vaccine developed to prevent the spread of a strain of the swine flu was linked to an as-yet-unexplained increase in cases of a rare neurological condition known as Guillain-Barre syndrome in those who received immunizations.
Note: For many powerful reports from reliable sources on the dangers of vaccines, click here.
Thimerosal and the Swine Flu Vaccine
July 29, 2009, ABC News blogs
Today at the CDC in Atlanta, health officials are huddled, trying to game plan the best way to dole out a vaccine for swine flu. But what about the vaccine preservative thimerosal? Here is what the CDC says about Thimerosal: "There is no convincing evidence of harm caused by the low doses of thimerosal in vaccines, except for minor reactions like redness and swelling at the injection site." Thimerosal is no longer used in all child vaccines made in the US except for the flu vaccine. Here is the CDC on Thimerosal and flu shots: "Yes, the majority of influenza vaccines distributed in the United States currently contain Thimerosal as a preservative. However, some contain only trace amounts of Thimerosal and are considered by the Food and Drug Administration (FDA) to be preservative-free." It would seem likely that the new Swine Flu vaccine therefore would contain some amount of Thimerosal. It would also seem likely that will give some parents pause.
Note: For a powerful article on a major cover-up around thimerosal written by Robert F. Kennedy, Jr., click here. For many powerful reports from reliable sources on the dangers of vaccines, click here.
Swine flu tally halted as school year fears loom
July 17, 2009, MSNBC
Worldwide cases of the new H1N1 swine flu virus are spreading so fast that overwhelmed global health officials have stopped counting and officials with the U.S Centers for Disease Control and Prevention say they'll soon follow suit. "We don't know the extent of the challenges that we'll face in the weeks and months ahead," said Dr. Anne Schuchat, director of the National Center for the Immunization and Respiratory Diseases. Schuchat did not elaborate on how the CDC would inform the public about the extent of the outbreak, which has been confirmed in more than 40,600 people and implicated in 263 deaths in the United States. WHO had reported nearly 95,000 cases including 429 deaths worldwide. Earlier Friday, WHO officials said tracking individual swine flu cases is too overwhelming for countries where the virus is spreading widely. WHO will no longer issue global totals of swine flu cases, although it will continue to track the global epidemic.
Note: Why would they stop counting cases? The numbers have always at best been estimates. Millions died in the 1918 flu epidemic and they have counted and reported those numbers extenstively. Could it be someone or some group does't want us to know how few are actually dying? For several other revealing articles which suggest an dangerous agenda with the swine flu vaccine, click here.
How Gary McKinnon became a cause celebre
August 4, 2009, BBC News
British computer hacker Gary McKinnon's fight against extradition to the US has drawn support from a large and diverse range of influential people. How did his case become such a cause celebre? Mr McKinnon has become Britain's best-known conspiracy theorist. Mr McKinnon does not deny he hacked into Pentagon systems, but claims he was searching for evidence of a UFO cover-up. The American authorities see it differently. The 43-year-old is a wanted man in the US, where he has been accused of "the biggest military computer hack of all time". For the past five years he has been fighting an extradition request from the American authorities which want to try him on US soil. If convicted there he faces up to 60 years in prison. Along the way he has amassed a legion of supporters, as diverse in their make up as they are distinguished in their own fields of achievement. They include novelist Nick Hornby, film critic Barry Norman, Emma Noble, the ex-glamour model and former daughter-in-law of John Major, Sting, his film producer wife Trudie Styler and actress Julie Christie. Politicians of all hues have also leapt on Mr McKinnon's case. And pop stars Chrissie Hynde and Sir Bob Geldof have teamed up with Gilmour to record a song of support. In the past six weeks his cause has been further bolstered by a high-profile campaign in the Daily Mail newspaper.
Can the Military Find the Answer to Alternative Energy?
July 23, 2009, BusinessWeek magazine
The big drive to create a viable alternative-energy future – by Detroit, multinationals such as IBM and BP, and Silicon Valley startups – is well-known. But there's another serious player in this sphere: the U.S. military, and especially DARPA [the Defense Advanced Research Projects Agency]. Created at the height of the Cold War to bolster U.S. military technology following the Soviet Union's Sputnik satellite launch, the agency has a long history of innovation. Most famously, DARPA's researchers first linked together computers at four locations in the early 1960s to form the ARPANET, a computer network for researchers that was the core of what eventually grew into the Internet. Other breakthroughs have helped lead to the commercial development of semiconductors, GPS, and UNIX, the widely used computer operating system. Can DARPA now score another double success by changing how both the military and civilian worlds consume and produce energy? DARPA's first goal is always to magnify the might of the U.S. armed forces. That's why Arlington (Va.)-based DARPA is devoting an estimated $100 million of its $3 billion annual budget to alternative energy. DARPA describes itself as an incubator of long-shot technologies too risky for almost anyone else to take on. The agency operates by issuing challenges to companies that are so tough they are called "DARPA-hard." Typically, DARPA requires contractors to come up with solutions that are orders of magnitude superior to current technology. In addition to spurring the development of palm-size fuel cells, DARPA has contracted with companies to miniaturize solar cells that would supplant the need for generators.
Solar Industry: No Breakthroughs Needed
August 3, 2009, MIT Technology Review
The federal government is behind the times when it comes to making decisions about advancing the solar industry, according to several solar-industry experts. This has led, they argue, to a misplaced emphasis on research into futuristic new technologies, rather than support for scaling up existing ones. That was the prevailing opinion at a symposium last week put together by the National Academies in Washington, DC, on the topic of scaling up the solar industry. The meeting was attended by numerous experts from the photovoltaic industry and academia. And many complained that the emphasis on finding new technologies is misplaced. "This is such a fast-moving field," said Ken Zweibel, director of the Solar Institute at George Washington University. "To some degree, we're fighting the last war. We're answering the questions from 5, 10, 15 years ago in a world where things have really changed." Industry experts at the Washington symposium argued that new technologies will take decades to come to market, judging from how long commercialization of other solar technologies has taken. Meanwhile, says Zweibel, conventional technologies "have made the kind of progress that we were hoping futuristic technologies could make." For example, researchers have sought to bring the cost of solar power to under $1 per watt, and as of the first quarter of this year one company, First Solar, has done this. These cost reductions have made solar power cheaper than the natural-gas-powered plants used to produce extra electricity to meet demand on hot summer days.
Note: Interesting that MIT has reported this story, but none of the major media picked it up. Solar energy will very likely be cheaper than oil-generated energy in under 10 years. For more on the current state of solar, click here.
Key Articles From Years Past
New documents show the monkey virus is present in more recent polio vaccine
July 22, 2001, San Francisco Chronicle (San Francisco's leading newspaper)
A monkey virus linked to human cancers may have contaminated the oral polio vaccine for years after the U.S. government ordered manufacturers to remove it. The Chronicle reported last week that the simian virus SV40 had contaminated early polio vaccine given to millions of Americans. When health officials discovered in 1961 that SV40 caused malignant tumors in lab animals, they ordered the virus eliminated from all future vaccine. But internal memos from Lederle Laboratories, the chief producer of polio vaccine in the United States, indicate SV40 may not have been completely removed. According to one memo, SV40 was found in three of 15 lots of the oral vaccine seven months after the federal directive was issued in March 1961. Lederle released the contaminated vaccine to the public anyway, the memo shows. Scientists discovered SV40 in the Salk polio vaccine in 1960. By then as many as 30 million Americans had been given injections of the SV40-tainted polio vaccine, which was first licensed in 1955. In recent years more than 60 scientific studies have found SV40 in rare human brain, bone and lung-related cancers, the same kinds of tumors the virus caused in laboratory animals. Some scientists believe SV40 may play a role in causing those cancers. The Lederle documents, which were obtained by Philadelphia attorney Stanley Kops in litigation not related to SV40, raise the possibility the virus might have been transmitted by contaminated oral vaccine, licensed for production in 1962.
Note: There are numerous major problems with how vaccines are monitored and developed, yet the media largely fails to address this major issue. For many powerful reports from reliable sources on the dangers of vaccines, click here. For lots more, click here and here.
Finding Balance: WantToKnow.info Inspiration Center
WantToKnow.info believes it is important to balance disturbing cover-up information with inspirational writings which call us to be all that we can be and to work together for positive change. For an abundance of uplifting material, please visit our Inspiration Center.
See our exceptional archive of revealing news articles.
www.momentoflove.org - Every person in the world has a heart
www.personalgrowthcourses.net - Dynamic online courses powerfully expand your horizons
www.WantToKnow.info - Reliable, verifiable information on major cover-ups
www.weboflove.org - Strengthening the Web of Love that interconnects us all
Subscribe here to the WantToKnow.info email list (two messages a week)